P112 The Prevalence of a positive screen for anxiety and/or depressive symptoms in HIV-1 infected patients in the UK - The CRANIum Study
R Kulasegaram¹, G Schembri², M Johnson³, C Leen⁴, P Hay⁵, V Lee⁶, A Price⁷, M Gompels⁸, A Naidoo⁹, J Van Wyk⁹, C De Alvaro⁹ and C Bayon^10
1Guy's and St Thomas', London, UK, ²Manchester Royal Infirmary, Manchester, UK, ³Royal Free Hospital, London, UK, ⁴Western General Hospital, Edinburgh, UK, ⁵St George's Hospital, London, UK, ⁶Manchester Royal Infirmary, Manchester, UK, ⁷Royal Victoria Infirmary, Newcastle-upon-Tyne, UK, ⁸Southmead Hospital, Bristol, UK, ⁹Abbott Laboratories, Paris, France, ¹⁰La Paz Hospital, Madrid, Spain

P113 Cardiovascular magnetic resonance reveals human immunodeficiency virus is an independent risk factor for vascular stiffness
M Asaad, O Rider, P Beak, E Wainwright, A Pitcher, G Hancock, G Clutton, L Dorrell and C Holloway
University of Oxford, Oxford, UK

P114 The emerging role of CT coronary calcium scoring in identifying patients of 'high' cardiovascular risk in the HIV population
C Cook, M Boffito, P Holmes, M Bower and M Nelson
Chelsea and Westminster Hospital, London, England

P115 How commonly is JC virus detected in the cerebrospinal fluid of patients with HIV?
J Bashford¹, M Atkins², M Bower¹ and M Nelson^1
1Chelsea and Westminster Hospital NHS Trust, London, UK, ²Imperial College Healthcare NHS Trust, London, UK

P116 Pancreatic insufficiency in patients with HIV: Didanosine is not the culprit (Poster not yet available)
T Martin¹, A Scourfield¹, N Rockwood¹, N Martin², N Patel³, M Nelson¹ and B Gazzard^1
1Chelsea and Westminster Hospital, London, UK, ²University of Bristol, Bristol, UK, ³Imperial College London, London, UK

P117 Tenofovir use may be associated with increased risk of loss of bone mineral density from spine but not from hip (Poster not yet available)
S Das¹, S Bopitya² and L David^3
1Coventry & Warwickshire Partnership Trust, Coventry, UK, ²George Elliot Hospital, Nuneaton, UK, ³St Cross Hospital, Rugby, UK

P118 The impact of HIV-1 infection, combination antiretroviral therapy and ageing on renal function
S Mandalia¹, SJ Westrop¹, EJ Beck², M Nelson³, K Farrington⁴, N Imami¹ and B Gazzard^3
1Department of Immunology, London, UK, ²London School of Hygiene and Tropical Medicine, London, UK, ³Department of HIV/GU Medicine, London, UK, ⁴Lister Hospital, Stevenage, UK

P119 Modelling the pathogenesis of HAND
D Ferguson¹, S Clarke¹, J Clements², N Berry¹ and N Almond^1
1National Institute of Biological Standards and Control, HPA, Potters Bar, Herts, UK, ²John Hopkins School of Medicine, Baltimore, Maryland, USA

P120 Comparison of tools to calculate cardiovascular risk in local HIV population
C Stradling¹, S Taheri², S Hussain² and S Taylor^1
1Heartlands HIV Service, Birmingham, UK, ²University of Birmingham, Birmingham, UK

P121 Secondary adrenal suppression and Cushing's syndrome caused by ritonavir boosted effects of inhaled fluticasone, injected triamcinolone and topical clobetasol: a case series
N Marshall, K Gurazada, P Bouloux, B Khoo and M Johnson
Royal Free Hospital NHS Trust, London, UK

P122 Antiretroviral therapy can be associated with increase in LDL apolipoprotein-B residence time without increase in LDLapo-B oxidation and glycation (Poster not yet available)
S Das¹, M Umpleby² and M Shahmanesh^3
1Coventry & Warwickshire Partnership Trust, Coventry, UK, ²University of Surrey, Guildford, UK, ³University of Birmingham, Birmingham, UK

P123 Incidence of rash in the 96-week analysis of the pooled Phase III randomised double-blind ECHO and THRIVE trials
C Orkin¹, J Arribas², S Hodder³, HJ Stellbrink⁴, S Vanveggel⁵, H Deckx⁵ and M Stevens^5
1Barts and The London NHS Trust, London, UK, ²Hospital Universitario La Paz, IdiPAZ, Madrid, Spain, ³UMDNJ-New Jersey Medical School, Newark, NJ, USA, ⁴ICH Study Center, Hamburg, Germany, ⁵Tibotec BVBA, Beerse, Belgium

P124 Comparison of modified Framingham and QRISK2-2011 cardiovascular risk assessment tools in a HIV-1 infected cohort
K Manavi, R McDermott and R Cramb
University Hospitals Birmingham, Birmingham, UK

P125 Cardiovascular risk screening in HIV positive patients: high risk patients one year on
S Dakshina, A Beardall, A Kay and C McCormick
Courtyard Clinic, St George's Hospital, London, UK

P126 Prevalence, and causes of chronic anaemia in HIV infected patients; implications for survival
K Manavi
University Hospitals Birmingham, Birmingham, UK

P127 A past history of syphilis is associated with poorer performance in the cognitive domains of memory and learning in HIV-infected subjects on stable cART
J Vera, L Garvey, C Tipple, D Goldmeier and A Winston
Imperial College London, St Mary's Hospital, London, UK

P128 A novel replacement and maintenance regimen for vitamin D deficient HIV positive patients
S Davies, J Freemantle, C Stradling, G Hickinbottom, M van der Linde, J Short and S Taylor
Heartlands Hospital, Birmingham, UK

P129 Comorbidities, cardiovascular risk factors and HIV: disease burden in an urban cohort over 40 years old (Poster not yet available)
A Hartley, M Peterzan and R O'Connell
Newham University Hospital, London, UK

P130 Factors associated with increased risk of tenofovir-related renal toxicity: case-control study
A Milinkovic¹, M Pavlou², A Furco¹, A Copas², A Arenas-Pinto¹, JO Connolly³, S Edwards¹, R Gilson¹ and I Williams^1
1Mortimer Market Centre, CNWL NHS Trust, London, UK, ²Research Department of Infection and Population Health, University College London, London, UK, ³Royal Free Hospital, London, UK

P131 Are traditional risk factors associated with cardiovascular events in HIV positive subjects?
R Daly, J Freemantle, G Koh, C Stradling, M van der Linde and S Taylor
Birmingham Heartlands Hospital, Birmingham, UK

P132 Cardiovascular risk scores in young adults with perinatally acquired HIV infection
S Johnston¹, MP Rhoads¹, S Nichols², S Fidler¹ and C Foster^2
1Imperial College London, London, UK, ²Imperial College NHS Trust, London, UK

P133 Outcomes of first raised ALT in HIV infection
C Lee¹, T Barber², E Devitt², HM Yapa², M Boffito² and M Nelson^2
1Imperial College London, London, UK, ²St Stephen's Centre, Chelsea and Westminster Hospital, London, UK

P134 An integrated approach to blood pressure control in HIV (Poster not yet available)
G Noble, I Reeves, R Jackson and L Abrahams
Homerton University Hospital, London, UK

P135 CD8 T-Cells in HIV related neurocognitive impairment (NCI)
T Rawson¹, S Mandalia¹, A Pozniak², P Kelleher¹, B Gazzard² and T Barber^2
1Imperial College London, London, UK, ²St Stephen's Centre, Chelsea and Westminster Hospital, London, UK

P136 Total hip arthroplasty in HIV-infected patients: what are the risk factors?
E Jackson¹, A Middleton², D Churchill² and K Walker-Bone^1
1Brighton & Sussex Medical School, Brighton, UK, ²Brighton & Sussex University Hospitals NHS trust, Brighton, UK

P137 Fracture risk in a cohort of HIV positive patients attending an inner-city HIV treatment centre
A Basra¹, M Joshi¹, P Saigal², H Webb², C McCormick² and M Pakianathan^2
1St George's University of London, London, UK, ²St George's Healthcare NHS Trust, London, UK

P138 Monitoring renal function in HIV infection: an audit to compare practice with the European AIDS Clinical Society guidelines
A Wolujewicz and M Kapembwa
North West London Hospitals NHS Trust, London, UK

P139 Mortality in the HAART era at an urban teaching hospital
M Toby, K Conway, S Lucas, N Larbalestier and R Kulasegaram
St Thomas' Hospital, London, UK

P140 Descriptive case series of eight HIV positive patients with foot stress fractures
S Chinthapalli, S Mandalia, R Jones, M Bower and M Nelson
Chelsea and Westminster Hospital, London, UK

P141 Steroids strike again – but where is the warning? (Poster not yet available)
K Conway, D Williams, K Walker-Bone and D Churchill
Lawson Unit, Brighton, England

P142 Can antiretrovirals increase the risk of venous thromboembolism in HIV-1 infection? (Poster not yet available)
A Scourfield, L Waters, T Martin, S Mandalia, M Bower, B Gazzard and M Nelson
Chelsea and Westminster Hospital, London, UK

P143 HIV meningoencephalitis secondary to compartmentalised viral escape with detection of X4 tropic virus in CSF (Poster not yet available)
S Singh, W Tong, J Mullen, S O'Shea and R Kulasegaram
Guy's & St Thomas' NHS Trust, London, UK

P144 Use of a novel online cortical test in HIV infected subjects undergoing screening for neurocognitive impairment
H Tam¹, D Ratcliffe², A Margetts², C Trustram Eve³, A Pozniak⁴, M Boffito⁴,P Catalan², B Gazzard⁴, S Mandalia¹ and T Barber^4
1Imperial College London, London, UK, ²Department of Psychological Medicine, Chelsea and Westminster Hospital, London, UK, ³foodforthebrain.org, Oxford, UK, ⁴St Stephen's Centre, Chelsea and Westminster Hospital, London, UK

P145 High incidence of overweight and obesity in a South London HIV clinic (Poster not yet available)
H Tate and C McCormick
St George's Healthcare NHS Trust, London, UK